HIV

New treatments for inflammatory conditions, cancer, and HIV are on the horizon. 

Top news of the day from across the health care landscape.

Enzyme acts as an epigenetic checkpoint of T cell function to treat cancer.

A look at the top stories in pharmacy last week.

Top articles of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Sexual risk behaviors are associated with increased HIV transmission and prevalence, yet women are largely understudied.

PrEP has been found to be effective in preventing HIV in high-risk populations.

The production of HIV-1 neutralizing antibodies correlated with self-reactive antibody levels,

Findings point towards an HIV vaccine that stimulates the production of these antibodies.

New cases of hepatitis C virus increased among young men by 55% in 2015.

Investigators aim to determine whether Zika virus interferes with antiretroviral drugs that prevent mother-to-child transmission of HIV.

Report finds socioeconomic factors that increase vulnerability to HIV.

Voluntary medical male circumcision may help to reduce the spread of HIV.

Opioids have caused more than 70% of health events among patients with drug use disorder around the world.

Patentiflorin A better inhibited viral replication than azidothymidine, which could lead to an HIV cure.

Increasingly, individuals with HIV also have comorbid conditions, such as cardiovascular disease, hypertension, and diabetes.

The once-daily drug contains bictegravir and emtricitabine/tenofovir to treat adults with HIV-1.

Competition in HIV drug development affecting stock market.

Inhibiting particle release and infectivity could lead to a cure for HIV-1.

The journal AIDS Care has published a systematic review that looks at the opportunity to provide coordinated care for HIV and non-communicable conditions.

Top news of the day from across the health care landscape.

Merck will present late-breaker abstracts at upcoming IAS 2017 conference.

The Biologics License Application for ibalizumab is under review for the treatment of multidrug resistant HIV-1.

Messaging based on patient medical records allow for more personalized care in HIV and other conditions.

Antibiotic resistance is making gonorrhea increasingly harder to treat, the World Health Organization (WHO) warned in a recently published report.

Walgreens today announced that beginning July 13, providers at Walgreens Healthcare Clinic locations in 17 new markets will be able to prescribe PrEP, a medication protocol for people who don’t have HIV to help proactively protect against HIV infection.

Top articles of the week from Specialty Pharmacy Times.